Today, Kenvue’s financial report for the second quarter reveals a nuanced performance, with net sales reaching $4.0 billion, a slight decrease of 0.3% compared to the previous year’s 5.4% increase. Despite this decline, the company achieved an organic growth of 1.5%, though this is lower than the 7.7% organic growth from the prior year. The organic growth consisted of a 2.1% increase in value realization, balanced by a 0.6% decrease in volume.
The company’s gross profit margin saw a significant improvement, expanding by 360 basis points to 59.1%, up from 55.5% in the same period last year. The adjusted gross profit margin increased even more, by 410 basis points, reaching 61.6% compared to 57.5% last year. These gains were driven by a combination of carry-over pricing and new price actions, along with productivity improvements from global supply chain efficiency initiatives.
Volume declines were primarily seen in the Skin Health and Beauty and Self Care segments, although this was partially offset by growth in the Essential Health segment. Despite these volume challenges, Kenvue reaffirmed its optimistic outlook for 2024, projecting net sales growth of 1.0%-3.0% and organic growth of 2.0%-4.0%, with adjusted diluted earnings per share expected to range between $1.10 and $1.20.
In specific segments, the Self Care division reported sales of $1.635 billion, a 1.6% decrease year-over-year. The company noted an improvement in year-over-year volume trends in Q2 compared to Q1, with strong performance in sun care later in the quarter offsetting a slow start to the season.
The Skin Health and Beauty segment achieved $1.103 billion in sales, a 3.8% year-over-year decline. However, this segment showed balanced growth between volume and value realization, with strong performance across all categories and regions, including notable global growth for Listerine.
